ID   GIMA5_RAT               Reviewed;         326 AA.
AC   Q8K3L6; Q5YEJ2; Q5YEJ3; Q8K3L7;
DT   14-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   02-OCT-2024, entry version 134.
DE   RecName: Full=GTPase IMAP family member 5;
DE   AltName: Full=Immunity-associated nucleotide 4 protein;
DE            Short=IAN-4;
DE   AltName: Full=Immunity-associated nucleotide 4-like 1 protein;
GN   Name=Gimap5;
GN   Synonyms=Ian4 {ECO:0000303|PubMed:12031988, ECO:0000303|PubMed:12930893,
GN   ECO:0000303|PubMed:15307172}, Ian4l1 {ECO:0000303|PubMed:15474297}, Iddm1,
GN   Lyp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), VARIANTS VAL-174 AND
RP   ILE-221, TISSUE SPECIFICITY, AND INVOLVEMENT IN INSULIN-DEPENDENT DIABETES
RP   AND T-CELL LYMPHOPENIA.
RC   STRAIN=BB; TISSUE=Thymus;
RX   PubMed=12031988; DOI=10.2337/diabetes.51.6.1972;
RA   Hornum L., Romer J., Markholst H.;
RT   "The diabetes-prone BB rat carries a frameshift mutation in Ian4, a
RT   positional candidate of Iddm1.";
RL   Diabetes 51:1972-1979(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=BB; TISSUE=Thymus;
RX   PubMed=15474297; DOI=10.1016/j.gene.2004.06.034;
RA   Andersen U.N., Markholst H., Hornum L.;
RT   "The antiapoptotic gene Ian4l1 in the rat: genomic organization and
RT   promoter characterization.";
RL   Gene 341:141-148(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12930893; DOI=10.1073/pnas.1832170100;
RA   Pandarpurkar M., Wilson-Fritch L., Corvera S., Markholst H., Hornum L.,
RA   Greiner D.L., Mordes J.P., Rossini A.A., Bortell R.;
RT   "Ian4 is required for mitochondrial integrity and T cell survival.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10382-10387(2003).
RN   [5]
RP   FUNCTION.
RX   PubMed=15307172; DOI=10.1002/eji.200324751;
RA   Lang J.A., Kominski D., Bellgrau D., Scheinman R.I.;
RT   "Partial activation precedes apoptotic death in T cells harboring an IAN
RT   gene mutation.";
RL   Eur. J. Immunol. 34:2396-2406(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=21487483; DOI=10.4161/self.1.3.12819;
RA   Wong V.W., Saunders A.E., Hutchings A., Pascall J.C., Carter C.,
RA   Bright N.A., Walker S.A., Ktistakis N.T., Butcher G.W.;
RT   "The autoimmunity-related GIMAP5 GTPase is a lysosome-associated protein.";
RL   Self/Nonself 1:259-268(2010).
RN   [7]
RP   FUNCTION, INTERACTION WITH MICROTUBULES, SUBCELLULAR LOCATION, TOPOLOGY,
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=28223986; DOI=10.3389/fimmu.2017.00094;
RA   Serrano D., Ghobadi F., Boulay G., Ilangumaran S., Lavoie C.,
RA   Ramanathan S.;
RT   "GTPase of the immune-associated nucleotide protein 5 regulates the
RT   lysosomal calcium compartment in T lymphocytes.";
RL   Front. Immunol. 8:94-94(2017).
CC   -!- FUNCTION: Required for mitochondrial integrity and T-cell survival. May
CC       contribute to T-cell quiescence. {ECO:0000269|PubMed:12930893,
CC       ECO:0000269|PubMed:15307172}.
CC   -!- FUNCTION: Plays a role in T lymphocyte development and the optimal
CC       generation of CD4/CD8 double-positive thymocytes (By similarity).
CC       Inhibitor of GSK3A, possibly by sequestering GSK3A in cytoplasmic
CC       vesicles and impairing its translocation to the nucleus. Consequently,
CC       impairs GSK3A-dependent transcriptional program and regulation of the
CC       DNA damage response occurring during T cells proliferation (By
CC       similarity). Required for the survival of peripheral T cells, natural
CC       killer (NK) and NK T-cell development and the maintenance of normal
CC       liver function (By similarity). Promotes the survival of quiescent T-
CC       cells (PubMed:15307172). May regulate Ca(2+) homeostasis by modulating
CC       lysosomal Ca(2+) stores, preventing its accumulation in the absence of
CC       T cell activation (PubMed:28223986). May play a role in mitochondrial
CC       DNA segregation in hematopoietic tissues (By similarity). Is a
CC       regulator of liver endothelial cell homeostasis (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BWF2, ECO:0000250|UniProtKB:Q96F15,
CC       ECO:0000269|PubMed:15307172, ECO:0000269|PubMed:28223986}.
CC   -!- SUBUNIT: Interacts with BAD, BAK1, BAX, BCL2, BCL2L1/Bcl-xL and
CC       BCL2L11/BimEL (By similarity). The interaction with BAX is increased,
CC       when cells initiate apoptosis upon IL2 withdrawal (By similarity).
CC       Forms a complex with BCL2L1 or MCL1 and HSPA8/HSC70; the interaction
CC       between HSPA8 and BCL2L1 or MCL1 is impaired in the absence of GIMAP5
CC       (By similarity). May interact (via N-terminus) with microtubules
CC       (Probable). {ECO:0000250|UniProtKB:Q8BWF2,
CC       ECO:0000305|PubMed:28223986}.
CC   -!- SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000269|PubMed:28223986};
CC       Single-pass type IV membrane protein {ECO:0000269|PubMed:28223986}.
CC       Endosome, multivesicular body membrane {ECO:0000269|PubMed:21487483};
CC       Single-pass type IV membrane protein {ECO:0000305}. Endosome membrane
CC       {ECO:0000269|PubMed:28223986}; Single-pass type IV membrane protein
CC       {ECO:0000269|PubMed:28223986}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Long, IAN4L1L, Gimap5v1 {ECO:0000303|PubMed:28223986};
CC         IsoId=Q8K3L6-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short, IAN4L1S, Gimap5v2
CC       {ECO:0000303|PubMed:28223986};
CC         IsoId=Q8K3L6-2; Sequence=VSP_008962;
CC   -!- TISSUE SPECIFICITY: Primarily expressed in spleen, heart, lung and
CC       intestine and, at lower levels, in kidney, stomach and muscle
CC       (PubMed:12031988). Expressed in thymus and lymph nodes (at protein
CC       level) (PubMed:12031988, PubMed:12930893, PubMed:21487483). In the
CC       spleen, expressed in periarteriolar lymphatic sheets (PubMed:12031988).
CC       Isoform 2: Expressed at higher levels in T lymphocytes compared to
CC       isoform 1 (PubMed:28223986). {ECO:0000269|PubMed:12031988,
CC       ECO:0000269|PubMed:12930893, ECO:0000269|PubMed:21487483,
CC       ECO:0000269|PubMed:28223986}.
CC   -!- DEVELOPMENTAL STAGE: Down-regulated during T lymphocyte activation.
CC       {ECO:0000269|PubMed:28223986}.
CC   -!- DISEASE: Note=Diabetes-prone biobreeding (DP-BB) rats have a frameshift
CC       mutation in Gimap5, which results in a truncated protein in which the
CC       C-terminal 215 amino acids, including the membrane anchor, are replaced
CC       by 19 other amino acids. These animals exhibit life-long T-cell
CC       lymphopenia, including lack of regulatory T cells, and spontaneously
CC       develop insulin-dependent diabetes resembling human type 1 diabetes.
CC       {ECO:0000269|PubMed:12031988}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like
CC       GTPase superfamily. AIG1/Toc34/Toc159-like paraseptin GTPase family.
CC       IAN subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY055776; AAL17698.1; -; mRNA.
DR   EMBL; AY055777; AAL17699.2; -; mRNA.
DR   EMBL; AY550018; AAS56933.1; -; mRNA.
DR   EMBL; AY550019; AAS56934.1; -; mRNA.
DR   EMBL; AY550020; AAS56935.1; -; mRNA.
DR   EMBL; AY550021; AAS56936.1; -; mRNA.
DR   EMBL; AY550022; AAS56937.1; -; mRNA.
DR   EMBL; AY550023; AAS56938.1; -; mRNA.
DR   EMBL; BC092561; AAH92561.1; -; mRNA.
DR   RefSeq; NP_001029085.1; NM_001033913.1. [Q8K3L6-1]
DR   RefSeq; NP_663713.1; NM_145680.3. [Q8K3L6-2]
DR   RefSeq; XP_006236519.1; XM_006236457.3.
DR   RefSeq; XP_006236520.1; XM_006236458.3. [Q8K3L6-2]
DR   RefSeq; XP_008761093.1; XM_008762871.2.
DR   AlphaFoldDB; Q8K3L6; -.
DR   SMR; Q8K3L6; -.
DR   STRING; 10116.ENSRNOP00000055929; -.
DR   PhosphoSitePlus; Q8K3L6; -.
DR   SwissPalm; Q8K3L6; -.
DR   PaxDb; 10116-ENSRNOP00000055929; -.
DR   Ensembl; ENSRNOT00000059156.3; ENSRNOP00000055929.3; ENSRNOG00000008416.8. [Q8K3L6-2]
DR   Ensembl; ENSRNOT00000084927.2; ENSRNOP00000072663.2; ENSRNOG00000008416.8. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00000115571.1; ENSRNOP00000078457.1; ENSRNOG00000008416.8. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00055046371; ENSRNOP00055038037; ENSRNOG00055026857. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00055046406; ENSRNOP00055038066; ENSRNOG00055026857. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00055046419; ENSRNOP00055038075; ENSRNOG00055026857. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00060051866; ENSRNOP00060043128; ENSRNOG00060029860. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00060051909; ENSRNOP00060043171; ENSRNOG00060029860. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00060051932; ENSRNOP00060043191; ENSRNOG00060029860. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00065025839; ENSRNOP00065020325; ENSRNOG00065015562. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00065025847; ENSRNOP00065020333; ENSRNOG00065015562. [Q8K3L6-1]
DR   Ensembl; ENSRNOT00065025854; ENSRNOP00065020340; ENSRNOG00065015562. [Q8K3L6-1]
DR   GeneID; 246774; -.
DR   KEGG; rno:246774; -.
DR   UCSC; RGD:628871; rat. [Q8K3L6-1]
DR   AGR; RGD:628871; -.
DR   CTD; 55340; -.
DR   RGD; 628871; Gimap5.
DR   eggNOG; ENOG502RB0C; Eukaryota.
DR   GeneTree; ENSGT00940000154844; -.
DR   InParanoid; Q8K3L6; -.
DR   OMA; YLAKVEW; -.
DR   OrthoDB; 938643at2759; -.
DR   PhylomeDB; Q8K3L6; -.
DR   TreeFam; TF330845; -.
DR   PRO; PR:Q8K3L6; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000008416; Expressed in thymus and 17 other cell types or tissues.
DR   ExpressionAtlas; Q8K3L6; baseline and differential.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0032585; C:multivesicular body membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0043011; P:myeloid dendritic cell differentiation; IMP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; IMP:RGD.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IMP:RGD.
DR   GO; GO:0050868; P:negative regulation of T cell activation; IMP:RGD.
DR   GO; GO:0032689; P:negative regulation of type II interferon production; IMP:RGD.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; IMP:RGD.
DR   GO; GO:0032831; P:positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; IMP:RGD.
DR   GO; GO:0045588; P:positive regulation of gamma-delta T cell differentiation; IMP:RGD.
DR   GO; GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IMP:RGD.
DR   GO; GO:0045838; P:positive regulation of membrane potential; IMP:RGD.
DR   GO; GO:0002729; P:positive regulation of natural killer cell cytokine production; IMP:RGD.
DR   GO; GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IMP:RGD.
DR   GO; GO:0046902; P:regulation of mitochondrial membrane permeability; IMP:RGD.
DR   GO; GO:0030217; P:T cell differentiation; IEP:RGD.
DR   GO; GO:0043029; P:T cell homeostasis; IMP:RGD.
DR   GO; GO:0001659; P:temperature homeostasis; IMP:RGD.
DR   CDD; cd01852; AIG1; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR006703; G_AIG1.
DR   InterPro; IPR045058; GIMA/IAN/Toc.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10903:SF180; GTPASE IMAP FAMILY MEMBER 5; 1.
DR   PANTHER; PTHR10903; GTPASE, IMAP FAMILY MEMBER-RELATED; 1.
DR   Pfam; PF04548; AIG1; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51720; G_AIG1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Endosome; GTP-binding; Lysosome; Membrane;
KW   Nucleotide-binding; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..326
FT                   /note="GTPase IMAP family member 5"
FT                   /id="PRO_0000190992"
FT   TOPO_DOM        1..297
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:28223986"
FT   TRANSMEM        298..318
FT                   /note="Helical; Anchor for type IV membrane protein"
FT                   /evidence="ECO:0000305|PubMed:28223986"
FT   TOPO_DOM        319..326
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:28223986"
FT   DOMAIN          42..245
FT                   /note="AIG1-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01057"
FT   BINDING         51..59
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WWP7"
FT   BINDING         72
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UG22"
FT   BINDING         169..171
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WWP7"
FT   BINDING         206
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WWP7"
FT   VAR_SEQ         1..32
FT                   /note="MEDHGFEELSTRTHDLNVRRLTKGNINFLLST -> MEGLQKSTYGTIVE
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12031988,
FT                   ECO:0000303|PubMed:15474297"
FT                   /id="VSP_008962"
FT   VARIANT         174
FT                   /note="A -> V"
FT                   /evidence="ECO:0000269|PubMed:12031988"
FT   VARIANT         221
FT                   /note="M -> I"
FT                   /evidence="ECO:0000269|PubMed:12031988"
SQ   SEQUENCE   326 AA;  37266 MW;  1452F22932FB5F51 CRC64;
     MEDHGFEELS TRTHDLNVRR LTKGNINFLL STGQETYSVE DSGLLRILLV GKSGCGKSAT
     GNSILRRPAF ESRLRGQSVT RTSQAEMGTW EGRSFLVVDT PPIFESKIQN QDMDKDIGNC
     YLMCAPGPHV LLLVTQLGRY TVEDAMAVRM VKQIFGVGVM RYMIVLFTHK EDLADESLEE
     FVTHTGNLDL HRLVQECGRR YCAFNNKASG EEQQGQLAEL MALVRRLEQE HEGSFHSNDL
     FVYTQVFLRG GYSEHQEPYK FYLTKVRQEV EKQKRELEEQ EGSWMAKMLC RVTSCLDWHI
     AVSVLLIVLG LTLLITLINM YIGRWK
//
